This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Efavirenz
ATRIPLA, SUSTIVA – Bristol-Myers Squibb Canada Co. (NOC Search)
Patents:
- 2101572: MYLAN, TEVA
- 2275323: TEVA
- 2279198: TEVA, MYLAN
- 2321523: TEVA
- 2332876: MYLAN, TEVA
MYLAN
- Appeal – A-278-11
- PM(NOC) – A-74-13 (2013 FCA 231) – T-2072-10 (2012 FC 1142, 2011 FC 919, 2013 FC 48)
TEVA
- PM(NOC) – A-92-14 (2015 FCA 3) – T-278-12 (2014 FC 30) – T-279-12 – T-912-12 – T-913-12 – T-914-12
Return to the Patented Medicine Litigation page.